OSUR - Orasure secures ~$512.9M contract for antigen test kits
Orasure (NASDAQ:OSUR) has been awarded a maximum ~$512.94M ID/IQ contract for over-the-counter antigen test kits. This is a one-year contract with no option periods. Location of performance is all 50 states, with a Sept. 14, 2022, ordering period end date. Primary customer is the Department of Health and Human Services. The contracting activity is the Defense Logistics Agency Troop Support, Pennsylvania. Also read: Quidel bags $710.6M Defense Logistics contract for antigen test And: Abbott bags ~$119.5M contract for antigen test And: Quidel bags $710.6M Defense Logistics contract for antigen test
For further details see:
Orasure secures ~$512.9M contract for antigen test kits